172 related articles for article (PubMed ID: 36568947)
1. Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer.
Ye T; Shao SH; Ji K; Yao SL
World J Gastrointest Oncol; 2022 Dec; 14(12):2367-2379. PubMed ID: 36568947
[TBL] [Abstract][Full Text] [Related]
2. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
3. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
[TBL] [Abstract][Full Text] [Related]
4. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
5. Safety and Long-Term Survival Outcome in Patients With Unresectable Barcelona Clinic Liver Cancer (BCLC) Stages C and D Advanced Hepatocellular Carcinoma Treated With 40 μm Drug-Eluting Bead Transcatheter Arterial Chemoembolization.
Wholey M; Palacios Iii R; Wholey D; Mendez A
Cureus; 2022 Apr; 14(4):e24047. PubMed ID: 35573558
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
7. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
8. [Analysis of curative effects of chemoembolization with drug-loaded microspheres of different particle sizes for the treatment of hepatocellular carcinoma].
Li Z; Ye BC; Xie RY; Wang YY; Zhang HT; Hu X; Li Y; Wu PL; Ge P; Yu BL; Wu B
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):612-617. PubMed ID: 36038322
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of CalliSpheres® Microsphere transcatheter-arterial chemoembolization versus conventional TACE in treating renal angiomyolipoma patients.
Lyu T; Wang J; Tong X; Mi T; An C; Zou Y
J Cancer Res Ther; 2023 Aug; 19(4):933-938. PubMed ID: 37675719
[TBL] [Abstract][Full Text] [Related]
10. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
12. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
13. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
14. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.
He JJ; Yin XX; Wang T; Chen MY; Li XL; Yang XJ; Shao HY
J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer.
Zhang C; Dai YH; Lian SF; Liu L; Zhao T; Wen JY
World J Clin Cases; 2022 Sep; 10(27):9650-9656. PubMed ID: 36186198
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.
Liu YS; Ou MC; Tsai YS; Lin XZ; Wang CK; Tsai HM; Chuang MT
Korean J Radiol; 2015; 16(1):125-32. PubMed ID: 25598680
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.
Hassanin TM; Fouad Y; Hassnine A; Eisawy M; Farag N; Abdel Ghany W
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1255-1261. PubMed ID: 33906320
[TBL] [Abstract][Full Text] [Related]
20. Chemoembolization of liver cancer with drug-loading microsphere 50-100μm.
Sun JH; Zhou GH; Zhang YL; Nie CH; Zhou TY; Ai J; Zhu TY; Wang WL; Zheng SS
Oncotarget; 2017 Jan; 8(3):5392-5399. PubMed ID: 28036272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
